Itrabin Tablet

Itraconazole 100 mg + Terbinafine 250 mg

Itrabin Tablet — Itraconazole 100 mg + Terbinafine 250 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Itraconazole 100 mg + Terbinafine 250 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Alu-Alu)
MRP ₹ 3280
Therapy Derma — Oral triazole + allylamine dual antifungal
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Itrabin Tablet

Itrabin Tablet combines the systemic triazole Itraconazole 100 mg with the systemic allylamine Terbinafine 250 mg. The pairing addresses recalcitrant dermatophyte infections, particularly the chronic relapsing tinea epidemic in India where monotherapy has shown high failure rates.

It is indicated for chronic recurrent tinea corporis/cruris, recalcitrant onychomycosis, deep dermatophyte infections and resistant pityriasis versicolor.

Camrut Healthcare manufactures Itrabin Tablet under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Chronic recurrent tinea corporis/cruris
  • Recalcitrant onychomycosis
  • Tinea pedis unresponsive to monotherapy
  • Resistant pityriasis versicolor
  • Deep fungal skin infection

Mechanism of Action

Itraconazole inhibits fungal 14-α-demethylase, blocking ergosterol synthesis. Terbinafine inhibits squalene epoxidase (earlier in the pathway), causing toxic squalene accumulation. The dual oral combination targets two sequential enzyme steps, providing additive activity and reducing resistance risk.

Dosage & Administration

['Adults: 1 tablet once daily after a meal (food enhances itraconazole absorption)', 'Tinea: 4 weeks', 'Onychomycosis: 6–12 weeks (toenails 12+ weeks)', 'Use under dermatologist supervision', 'Monitor LFTs']

Side Effects

['GI upset', 'Headache', 'Taste disturbance (terbinafine)', 'Hepatotoxicity (rare — monitor LFTs)', 'Drug interactions via CYP3A4 (itraconazole)']

Contraindications & Precautions

['Significant hepatic impairment', 'Heart failure (itraconazole — negative inotropic)', 'Concurrent CYP3A4 substrates with narrow therapeutic index', 'Pregnancy and breastfeeding', 'Severe renal impairment']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Itrabin Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.